Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001628280-18-001419
Filing Date
2018-02-12
Accepted
2018-02-12 16:04:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A went2018sechdule13g.htm SC 13G/A 90635
  Complete submission text file 0001628280-18-001419.txt   92018
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88106 | Film No.: 18596337
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220 EMERYVILLE CA 94608
Business Address
Went Gregory T (Filed by) CIK: 0001604541 (see all company filings)

Type: SC 13G/A